DOI: 10.18413/2658-6533-2021-7-2-0-2

**Association of polymorphism of genes STAT3, IL10 and IL12B with a viral load in women with human papillomavirus**

Background: HPV infection leads to an imbalance of pro- and anti-inflammatory cytokines, which contributes to the long-term persistence of the virus in infected cells. The aim of the study: To investigate the association of polymorphisms of genes STAT3 G>C (rs2293152), IL10 -1082 G>A (rs1800896) and IL12B 1188A>C (rs3212227) with a high viral load of human Papillomavirus (HPV), and the influence of gene-gene interactions on the human papillomavirus prolonged infection. Materials and methods: 104 women with a high HPV load and 110 healthy women were involved in a case-control study. Genotyping of SNPs for IL10 -1082G>A, IL12B 1188A>C was performed by allele-specific PCR; the rs2293152 STAT3 G>C gene was carried out by restriction fragment length polymorphism (RFLP). Gene-gene interactions were analyzed using the multifactor dimensionality reduction (MDR) algorithm. Results: The study of single individual SNPs of the STAT3 G>C (rs2293152), IL10 -1082 G>A (rs1800896) and IL12B 1188A>C (rs3212227) genes did not reveal a statistically significant difference in genotypes and alleles frequencies in women with a high HPV load and the control group. The MDR analysis showed a significance of intergenic interactions of the studied loci rs2293152 – rs1800896 – rs3212227 for the formation of a high HPV load (OR=2.62, 95%=1.51-4.57, p=0.0006, p_bonf=0.002). Conclusion: The interaction of genes STAT3 (rs2293152) – IL10 (rs1800896) – IL12B (rs3212227) is associated with the risk of a high HPV load in women.

Keywords: human papillomavirus (HPV), cytokines, viral load, polymorphism, STAT3, IL10, IL12B.

Number of views: 1234 (view statistics)

Количество скачиваний: 3205

Full text (HTML)Full text (PDF)To articles list

Information for citation:

AlBosale AHH. Association of polymorphism of genes STAT3, IL10 and IL12B with a viral load in women with human papillomavirus. Research Results in Biomedicine. 2021;7(2):117-131. Russian]. DOI: 10.18413/2658-6533-2021-7-2-0-2

User comments
Reference lists

While nobody left any comments to this publication.
You can be first.

Chan CK, Aimagambetova G, Ukybassova T, et al. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination — Review of Current Perspectives. Journal of Oncology. 2019;2019:3257939. DOI: https://doi.org/10.1155/2019/3257939
Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 17 June 2019 [Internet]. 2019 [cited 2021 Jan 21];22. Available from: https://www.hpvcentre.net/statistics/reports/XWX.pdf.
Burger EA, Kim JJ, Sy S, et al. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer. Clinical Infectious Diseases. 2017;65(6):893-9. DOI: https://doi.org/10.1093/cid/cix475
Shanmugasundaram S, You J. Targeting Persistent Human Papillomavirus Infection. Viruses. 2017;9(8):229. DOI: https://doi.org/10.3390/v9080229
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020;8(2):e191-203. DOI: https://doi.org/10.1016/S2214-109X(19)30482-6
Li B, Zhang L, Zhao J, et al. The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix. Infectious Agents and Cancer. 2019;14:16. DOI: https://doi.org/10.1186/s13027-019-0231-z
Fernandes JV, De Medeiros Fernandes TAA, De Azevedo JCV, et al. Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). Oncology Letters. 2015;9(3):1015-26. DOI: https://doi.org/10.3892/ol.2015.2884
Daniilidis A, Koutsos J, Oikonomou Z, et al. Cytokines of Cervical Mucosa and Human Papilloma Virus Infection of the Cervix: A Descriptive Study. Acta Cytologica. 2016;60:58-64. DOI: https://doi.org/10.1159/000445161
Woodby B, Scott M, Bodily J. The Interaction Between Human Papillomaviruses and the Stromal Microenvironment. Progress in Molecular Biology and Translational Science. 2016;144:169-238. DOI: https://doi.org/10.1016/bs.pmbts.2016.09.003
Setrerrahmane S, Xu H. Tumor-related interleukins: old validated targets for new anti-cancer drug development. Molecular Cancer. 2017;16:153. DOI: https://doi.org/10.1186/s12943-017-0721-9
Lee H, Jeong AJ, Ye S-K. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Reports. 2019;52(7):415-23. DOI: https://doi.org/10.5483/BMBRep.2019.52.7.152
Morgan EL, Wasson CW, Hanson L, et al. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathogens. 2018;14(4):e1006975. DOI: https://doi.org/10.1371/journal.ppat.1006975
Lin W, Niu Z, Zhang H, et al. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer. International Journal of Clinical and Experimental Pathology. 2019;12(9): 3604-3612.
Guadagnin E, Narola J, Bönnemann CG, et al. Tyrosine 705 Phosphorylation of STAT3 Is Associated with Phenotype Severity in TGF β 1 Transgenic Mice. BioMed Research International. 2015;2015:843743. DOI: https://doi.org/10.1155/2015/843743
Mitchell RE, Hassan M, Burton BR, et al. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. Scientific Reports. 2017;7:11315. DOI: https://doi.org/10.1038/s41598-017-11803-y
Floss DM, Moll JM, Scheller J. IL-12 and IL-23—Close Relatives with Structural Homologies but Distinct Immunological Functions. Cells. 2020;9(10):2184. DOI: https://doi.org/10.3390/cells9102184
Berraondo P, Etxeberria I, Ponz-Sarvise M, et al. Revisiting Interleukin-12 as a Cancer Immunotherapy Agent. Clinical Cancer Research. 2018;24(12):2716-8. DOI: https://doi.org/10.1158/1078-0432.CCR-18-0381
Álvarez-Salamero C, Castillo-González R, Pastor-Fernández G, et al. IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics. PLoS Biology. 2020;18(3):e3000646. DOI: https://doi.org/10.1371/journal.pbio.3000646
Alves JJP, Fernandes TAADM, de Araujo JMG, et al. Th17 response in patients with cervical cancer (Review). Oncology Letters. 2018;16(5):6215-27. DOI: https://doi.org/10.3892/ol.2018.9481
Jang J-P, Baek I-C, Choi E-J, et al. Multiplex Genotyping of Cytokine Gene SNPs Using Fluorescence Bead Array. PLoS ONE. 2015;10(2):e0118008. DOI: https://doi.org/10.1371/journal.pone.0118008
Guo Y, Jamison DC. The distribution of SNPs in human gene regulatory regions. BMC Genomics. 2005;6:140. DOI: https://doi.org/10.1186/1471-2164-6-140
Kirchner S, Cai Z, Rauscher R, et al. Alteration of protein function by a silent polymorphism linked to tRNA abundance. PLoS Biology. 2017;15(5):e2000779. DOI: https://doi.org/10.1371/journal.pbio.2000779
Lesiak A, Zakrzewski M, Przybyłowska K, et al. Atopic dermatitis patients carrying G allele in –1082 G/A IL-10 polymorphism are predisposed to higher serum concentration of IL-10. Archives of Medical Science. 2014;10(6):1239-43. DOI: https://doi.org/10.5114/aoms.2014.47833
Hoffmann TW, Halimi J-M, Büchler M, et al. Impact of a Polymorphism in the IL-12p40 Gene on the Outcome of Kidney Transplantation. Transplantation Proceedings. 2009;41(2):654-6. DOI: https://doi.org/10.1016/j.transproceed.2008.12.002
Shi X, Jia Y, Xie X, et al. Single-nucleotide polymorphisms of the IL-12 gene lead to a higher cancer risk: a meta-analysis based on 22,670 subjects. Genes and Genetic Systems. 2017;92(4):173-87. DOI: https://doi.org/10.1266/ggs.16-00024
Doorbar J, Egawa N, Griffin H, et al. Human papillomavirus molecular biology and disease association. Reviews in Medical Virology. 2015;25(51):2-23. DOI: https://doi.org/10.1002/rmv.1822
Obeid DA, Almatrrouk SA, Khayat HH, et al. Human papillomavirus type 16 and 18 viral loads as predictors associated with abnormal cervical cytology among women in Saudi Arabia. Heliyon. 2020;6(2):e03473. DOI: https://doi.org/10.1016/j.heliyon.2020.e03473
Gupta SM, Mania-Pramanik J. Retraction Note: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. Journal of Biomedical Science. 2019;26:28. DOI: https://doi.org/10.1186/s12929-019-0520-2
Shen YY, Du H, Liu ZH, et al. The relationship between the human papillomavirus viral load and the degree of pathology in the cervical intraepithelial neoplasia. Chinese Journal of Clinical Obstetrics and Gynecology. 2017;18(4):313-316.
Del Río-Ospina L, Soto-De León SC, Camargo M, et al. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions. BMC Cancer. 2015;15:100. DOI: https://doi.org/10.1186/s12885-015-1126-z
Morgan EL, Macdonald A. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1—NFκB—IL-6 signalling axis. PLoS Pathogens. 2019;15(6):e1007835. DOI: https://doi.org/10.1371/journal.ppat.1007835
Walch-Rückheim B, Pahne-Zeppenfeld J, Fischbach J, et al. STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs. Cancer Research. 2016;76(13):3872-83. DOI: https://doi.org/10.1158/0008-5472.CAN-14-1306
Zyuzkov GN, Udut EV, Miroshnichenko LA, et al. The specific role of JAK / STAT3-signaling in the regulation of the functions of mesenchymal progenitor cells. Bulletin of Experimental Biology and Medicine. 2017;164(9):294-7. Russian.
Morgan EL, Macdonald A. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies. Viruses. 2020;12(9):977. DOI: https://doi.org/10.3390/v12090977
Yan R, Lin F, Hu C, et al. Association between STAT3 polymorphisms and cancer risk: a meta-analysis. Molecular Genetics and Genomics. 2015;290:2261-70. DOI: https://doi.org/10.1007/s00438-015-1074-y
Rojas JM, Avia M, Martín V, et al. IL-10: a multifunctional cytokine in viral infections. Journal of Immunology Research. 2017;2017:6104054. DOI: https://doi.org/10.1155/2017/6104054
Wang B, Wang H, Li P, et al. Relationships of interleukin-10 with the regulatory T cell ratio and prognosis of cervical cancer patients. Clinics. 2018;73. DOI: https://doi.org/10.6061/clinics/2018/e679
Larsson L, Johansson P, Jansson A, et al. The Sp1 transcription factor binds to the G-allele of the –1087 IL-10 gene polymorphism and enhances transcriptional activation. Genes and Immunity. 2009;10:280-4. DOI: 1 https://doi.org/10.1038/gene.2008.79
Farzaneh F, Roberts SA, Mandal D, et al. The IL-10 −1082G polymorphism is associated with clearance of HPV infection. BJOG: An International Journal of Obstetrics and Gynaecology. 2006;113(8):961-4. DOI: https://doi.org/10.1111/j.1471-0528.2006.00956.x
Chagas BS, de Lima RCP, Júnior SSLP, et al. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus. Cytokine. 2019;113:99-104. DOI: https://doi.org/10.1016/j.cyto.2018.06.014
Zeng YY, Chen XY, Tian KG, et al. The correlation of interleukin-10 gene polymorphism and HPV infection and cervical lesions in Dongguan region. Journal of Clinical and Experimental Medicine. 2015;14:636-639.
Datta A, Zahora FT, Aziz MA, et al. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. International Immunopharmacology. 2020;89(B):107091. DOI: https://doi.org/10.1016/j.intimp.2020.107091
Tugues S, Burkhard SH, Ohs I, et al. New insights into IL-12-mediated tumor suppression. Cell Death and Differentiation. 2015;22:237-46. DOI: https://doi.org/10.1038/cdd.2014.134
Yan J, Smyth MJ, Teng MWL. Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer. Cold Spring Harbor perspectives in biology. 2018;10:a028530. DOI: https://doi.org/10.1101/cshperspect.a028530
Rébé C, Ghiringhelli F. STAT3, a Master Regulator of Anti-Tumor Immune Response. Cancers (Basel). 2019;11(9):1280. DOI: https://doi.org/10.3390/cancers11091280
Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nature Genetics. 2001;27:218-21. DOI: https://doi.org/10.1038/84872
Schurich A, Raine C, Morris V, et al. The role of IL-12/23 in T cell–related chronic inflammation: implications of immunodeficiency and therapeutic blockade. Rheumatology. 2018;57(2):246-54. DOI: https://doi.org/10.1093/rheumatology/kex186
Han S-S, Cho E-Y, Lee TS, et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2008;140(1):71-5. DOI: https://doi.org/10.1016/j.ejogrb.2008.02.007
Tamandani DMK, Shekari M, Suri V. Interleukin-12 Gene Polymorphism and Cervical Cancer Risk. American Journal of Clinical Oncology. 2009;32(5):524-8. DOI: https://doi.org/10.1097/COC.0b013e318192519a
Roszak A, Mostowska A, Sowińska A, et al. Contribution of IL12A and IL12B Polymorphisms to the Risk of Cervical Cancer. Pathology and Oncology Research. 2012;18:997-1002. DOI: https://doi.org/10.1007/s12253-012-9532-x
Ramírez-Bello J, Jiménez-Morales M. Functional implications of single nucleotide polymorphisms (SNPs) in protein-coding and non-coding RNA genes in multifactorial diseases. Gaceta Medica de Mexico. 2017;153:238-50.
Wang K, Zhou B, Zhang J, et al. Association of Signal Transducer and Activator of Transcription 3 Gene Polymorphisms with Cervical Cancer in Chinese Women. DNA and Cell Biology. 2011;30(11):931-6. DOI: https://doi.org/10.1089/dna.2010.1179
Gutiérrez-Hoya A, Soto-Cruz I. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins. Cells. 2020;9(10):2297. DOI: https://doi.org/10.3390/cells9102297

All journals

Send article

Research Results in Biomedicine is included in the scientific database of the RINTs (license agreement No. 765-12/2014 dated 08.12.2014).

The journal is included in the list of peer-reviewed scientific publications recommended by the Higher Attestation Commission

The journal is indexed by the following scientific databases and platforms

Research Results in Biomedicine (ISSN 2658-6533)

The journal materials and website are licensed under Creative Commons «Attribution» 4.0 International.

The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"The Founder’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

The Publisher: Federal State Autonomous Educational Institution of HigherEducation "Belgorod National Research University" The Founder’s address:85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

Editors Office: chief editor Mikhail I. Churnosov, e-mail: RR_MedPharm@bsuedu.ru, phone: +7 (4722) 30-14-03.

Regulations on the Journal

Certificate

Have questions?
You can write to us:

✉ Executive Secretary

✉ Site administration

✉ Content manager